Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A C Ford

Showing results (1-10 of 91) with videos related to

Pageof 10
Sort By:
Alimentary Pharmacology & Therapeutics|July 20, 2010
Dyspepsia and irritable bowel syndrome: mutually exclusive conditions?A C Ford
Alimentary Pharmacology & Therapeutics|April 27, 2010
Probiotics in irritable bowel syndrome: underachievers or underpowered?A C Ford
Minerva Gastroenterologica E Dietologica|October 16, 2009
Management of irritable bowel syndromeA C Ford
Alimentary Pharmacology & Therapeutics|November 3, 2010
Reporting of relapse rates in a trial of mesalazine for ulcerative colitisA C Ford
Alimentary Pharmacology & Therapeutics|December 17, 2009
Applicability of the reported prevalence of bile salt malabsorption in irritable bowelA C Ford
Alimentary Pharmacology & Therapeutics|July 6, 2010
Renzapride in IBS: is efficacy in the eye of the beholder?A C Ford
Alimentary Pharmacology & Therapeutics|April 27, 2010
Alverine citrate, simeticone, and Rome III irritable bowel syndromeA C Ford
The American Journal of Gastroenterology|November 5, 2010
Low yield of colonoscopy in individuals with suspected irritable bowel syndrome?A C Ford
Alimentary Pharmacology & Therapeutics|October 28, 2009
Generalized anxiety disorder and irritable bowel syndromeA C Ford
Alimentary Pharmacology & Therapeutics|January 9, 2014
Letter: effects of iron therapy after non-variceal acute upper gastrointestinal bleedingE Bounford, A C Ford
Pageof 10

Showing results (1-10 of 91) with videos related to

Sort By:
Pageof 10
Alimentary Pharmacology & Therapeutics|July 20, 2010
Dyspepsia and irritable bowel syndrome: mutually exclusive conditions?A C Ford
Alimentary Pharmacology & Therapeutics|April 27, 2010
Probiotics in irritable bowel syndrome: underachievers or underpowered?A C Ford
Minerva Gastroenterologica E Dietologica|October 16, 2009
Management of irritable bowel syndromeA C Ford
Alimentary Pharmacology & Therapeutics|November 3, 2010
Reporting of relapse rates in a trial of mesalazine for ulcerative colitisA C Ford
Alimentary Pharmacology & Therapeutics|December 17, 2009
Applicability of the reported prevalence of bile salt malabsorption in irritable bowelA C Ford
Alimentary Pharmacology & Therapeutics|July 6, 2010
Renzapride in IBS: is efficacy in the eye of the beholder?A C Ford
Alimentary Pharmacology & Therapeutics|April 27, 2010
Alverine citrate, simeticone, and Rome III irritable bowel syndromeA C Ford
The American Journal of Gastroenterology|November 5, 2010
Low yield of colonoscopy in individuals with suspected irritable bowel syndrome?A C Ford
Alimentary Pharmacology & Therapeutics|October 28, 2009
Generalized anxiety disorder and irritable bowel syndromeA C Ford
Alimentary Pharmacology & Therapeutics|January 9, 2014
Letter: effects of iron therapy after non-variceal acute upper gastrointestinal bleedingE Bounford, A C Ford
Pageof 10